2013 - CTS 2013 Congress


State of the Art: Muscle, Bone, and Cartilage

7.2 - Engineering Novel Cellular Products for the Regeneration of the Musculoskeletal Tissues

Presenter: Pier Maria, Fornasari, Bologna, Italy
Authors: Pier Maria Fornasari


The regeneration of musculoskeletal tissues is a very promising scientific area and is getting increasing clinical results in tendon, soft tissues and bone healing.

Musculoskeletal tissues regeneration covers many different surgical specialties like orthopedics, spine surgery, sport medicine,  dental implantology, maxillo-facial surgery and neurosurgery.

The tissue regeneration requires a scaffold with or without human stem cells.

The cellular product used can be autologous or allogeneic and minimally or more than minimally manipulated.

In the minimal manipulation case,  the cells are isolated from the donor tissue using methods not altering the cells fundamental characteristics. An example of physical method for obtaining mesenchymal stem cells from adipose tissue will be presented.

If a cell is minimally manipulated and the use is considered homologous (same function in donor and recipient) the procedure is considered a cell transplantation.

In the more than minimal manipulation case, like enzymatic isolation and culture expansion, the cells are defined altered and thus GMP production and "drug like" clinical cGCP path is required.

Several products are already available for clinical use in musculoskeletal regeneration and many others are in pipeline.      


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi